Symptoms of attention-deficit hyperactivity disorder (ADHD) have been found in several studies of children with intellectual disabilities (ID) but the two diseases are not always associated. Several lines of evidence implicate the involvement of brain-derived neurotrophic factor (BDNF) in ADHD, and it may also be relevant in ID due to its known involvement in the development of the central nervous system (CNS) and in learning/memory functions. We genotyped paediatric patients with ADHD and ID for the Val66Met and 270 C/T polymorphisms in BDNF. Diagnosis of ADHD and ID was confirmed by the clinicians in accordance with DSM-IV criteria. The G/A genotype of the Val66Met SNP was associated with both ADHD and ID, and the G allele was significantly associated with ADHD. The C/C genotype of the C270T SNP was significantly overrepresented in both ADHD and ID groups compared with the controls. Data suggest that both BDNF polymorphisms could play a role in the etiology of ADHD. In addition, we present the first results suggesting that these BDNF SNPs are significantly associated with ID.
BerndP. The role of neurotrophins during early development. Gene Expr2008; 14:241–50.
2.
CargillMAltshulerDIrelandJ. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics1999; 22:231–8.
3.
KunugiHUekiAOtsukaM. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associatedwith late-onset Alzheimer's disease. Mol Psychiatry2001; 6:83–86.
4.
ChenZYPatelPDSantG. Variant brainderived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild type BDNF in neurosecretory cells and cortical neurons. J Neurosci2004; 24:4401–11.
5.
AureliASebastianiPDel BeatoT. Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation. Int J Immunopathol Pharmacol2008; 21:985–91.
BlochlASirrenbergC. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem1996; 271:21100–7.
8.
NaritaMAokiKTakagiMYajimaYSuzukiT. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience2003; 119:767–75.
9.
MostertJPKochMWHeeringsMHeersemaDJDe KeyserJ. Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther2008; 14:153–64.
10.
KernieSGLieblDJParadaLF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J2000; 19:1290–300.
11.
RiosMFanGFeketeC. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol2001; 15:1748–57.
12.
SagvoldenTRussellVAAaseHJohansenEBFarshbafM. Rodent models of attention-deficit/ hyperactivity disorder. Biol Psychiatry2005; 57:1239–47.
13.
McCormickLH. Depression in mothers of children with attention-deficit hyperactivity disorder. Fam Med1995; 27:176–9.
14.
TsaiSJ. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med Hypotheses2007; 68:896–9.
15.
ConoverJCEricksonJTKatzDM. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature1995; 375:235–8.
16.
FilipekP.A.Semrud-ClikemanMSteingardRJ. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology1997; 48:589–601.
17.
CellerinoACarrollPThoenenHBardeYA. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci1997; 9:397–408.
18.
OvermeyerSBullmoreE TSucklingJ. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med2001; 31:1425–35.
PooMM. Neurotrophins as synaptic modulators. Nat Rev Neurosci2001; 2:24–32.
21.
EganMFKojimaMCallicottJH. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell2003; 112:257–69.
22.
LippmannMBressANemeroffCB. Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci2007; 25:3091–8.
23.
YuHZhangZShiY. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry2008; 69:1104–11.
24.
LanktreeMMugliaPSquassinaA. A potential role for brain-derived neurotrophic factor (BDNF) in adult ADHD. Am J Med Gent2004; 130B:96–7.
25.
KentLGreenEHawiZ. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry2005; 10:939–43.
26.
SchimmelmannBGFriedelSDempfleA. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J Neural Transm2007; 114:523–6.
27.
XuXMillJZhouK. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet2007; 144B:83–6.
28.
GadowKDRoohiJDevincentCJ. Association of COMT (Val158Met) and BDNF (Val66Met) Gene Polymorphisms with Anxiety, ADHD and tics in children with autism spectrum disorder. J Autism Dev Disord2009; 39:1542–51.
29.
Sánchez-MoraCRibasésMRamos-QuirogaJA. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet2010; 153B:512–23.
30.
HaririARGoldbergTEMattayVS. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci2003; 23:6690–4.
